Custus®YRS
Enteric Redmouth Disease in salmonids (Yersinia ruckeri)
ApprovedActive
Key Facts
Indication
Enteric Redmouth Disease in salmonids (Yersinia ruckeri)
Phase
Approved
Status
Active
Company
About ACD Pharma
ACD Pharma is a private Norwegian biotech firm at the forefront of bacteriophage therapeutics. It has successfully commercialized a product for aquaculture (Custus®YRS) and is translating its technological platform to address critical human health challenges, particularly antibiotic-resistant infections like Klebsiella pneumoniae. The company is strategically positioned with strong academic and clinical partnerships and is scaling manufacturing capabilities with a new facility in Lofoten, aiming to become a key player in the global fight against antimicrobial resistance.
View full company profile